Objective Metabolomic studies suggest plasma levels of bile acids (BAs) are elevated
amongst subjects with non-alcoholic fatty liver disease (NAFLD) compared to healthy …

Bile acids (BAs) have many physiological roles and exhibit both toxic and protective
influences within the liver. Alterations in the BA profile may be the result of disease induced …

Abstract Background Bile acids (BAs) are synthesized by the liver and modified by gut
bacteria, and may play an intermediary role between the gut microbiome and liver in …

Abstract Background and Aims The prevalence of nonalcoholic fatty liver disease (NAFLD)
and steatohepatitis (NASH) is increasing at an alarming rate. The role of bile acids in the …

The histologic spectrum of nonalcoholic fatty liver disease (NAFLD) includes fatty liver
(NAFL) and steatohepatitis (NASH), which can progress to cirrhosis in up to 20% of NASH …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is characterized by dysbiosis.
The bidirectional effects between intestinal microbiota (IM) and bile acids (BA) suggest that …

Abstract Context Bile acids (BAs) are signaling molecules controlling energy homeostasis
that can be both toxic and protective for the liver. BA alterations have been reported in …

Background & Aims Plasma bile acids (BAs) have been extensively studied as
pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from …

Background The fasting‐state serum bile acid profile in nonalcoholic fatty liver disease
(NAFLD) has been reported to differ when nonalcoholic steatohepatitis is compared to …

A significant increase of bile acid (BA) levels has been recognized as a general metabolic
phenotype of diverse liver diseases. Monitoring of BA profiles has been proposed for …